Currently out of the existing stock ratings of Joon Lee, 187 are a BUY (89.9%), 20 are a HOLD (9.62%), 1 are a SELL (0.48%).

Joon Lee

Work Performance Price Targets & Ratings Chart

Analyst Joon Lee, currently employed at TRUIST, carries an average stock price target met ratio of 48.29% that have a potential upside of 63.97% achieved within 252 days.

Joon Lee’s has documented 395 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on JAZZ, Jazz Pharmaceuticals PLC at 09-Jun-2026.

Wall Street Analyst Joon Lee

Analyst best performing recommendations are on NTLA (INTELLIA THERAPEUTICS).
The best stock recommendation documented was for CORT (CORCEPT THERAPEUTICS) at 8/2/2023. The price target of $29 was fulfilled within 1 day with a profit of $3.99 (15.95%) receiving and performance score of 159.54.

Average potential price target upside

of $83.34 (151.03%) on PRAX (PRAXIS PRECISION MEDICINES ).
of $66.79 (16.26%) on VRTX (VERTEX PHARMACEUTICALS).
of $65.81 (47.4%) on JAZZ (JAZZ PHARMACEUTICALS PLC).

ADVM Adverum Biotechnologies ALKS Alkermes Plc ARGX argenx NV ADR ARVN Arvinas AXSM Axsome Therapeutics BMRN Biomarin Pharmaceutical CNCE Concert Pharmaceuticals CORT Corcept Therapeutics CPRX Catalyst Pharmaceuticals CRMD CorMedix CRSP Crispr Therapeutics AG EDIT Editas Medicine GBT Global Blood Therapeutics JAZZ Jazz Pharmaceuticals PLC LBPH Longboard Pharmaceuticals LJPC La Jolla Pharmaceutical Co LRMR Larimar Therapeutics NTLA Intellia Therapeutics PRAX Praxis Precision Medicines PTCT PTC Therapeutics SAGE Sage Therapeutic VKTX Viking Therapeutics VRNA Verona Pharma PLC ADR VRTX Vertex Pharmaceuticals VYGR Voyager Therapeutics WVE Wave Life Sciences Ltd

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Matthew Caufield (HC WAINWRIGHT)